Location History:
- Jeoneup-si, KR (2017)
- Daejeon, KR (2018)
Company Filing History:
Years Active: 2017-2018
Title: Yong Mo Kim: Innovator in Biopharmaceuticals
Introduction
Yong Mo Kim is a prominent inventor based in Jeoneup-si, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapeutic formulations. With a total of 2 patents to his name, Kim's work focuses on enhancing the efficacy and stability of protein-based treatments.
Latest Patents
Kim's latest patents include a stable liquid formulation of a fusion protein with an IgG Fc domain. This formulation is designed to improve therapeutic effects on various ophthalmic diseases, such as retinal vein occlusion and diabetic macular edema. The invention aims to stabilize bioactivity through a formulation suitable for intravitreal injection of an anti-VEGF-Fc fusion protein, including aflibercept. Another notable patent involves a modified antibody in which a motif comprising a cysteine residue is bound. This modified antibody-drug conjugate can accurately deliver drugs to target cells, enhancing the therapeutic effect while increasing the usability of anticancer drugs.
Career Highlights
Yong Mo Kim is currently associated with Alteogen, Inc., where he continues to innovate in the biopharmaceutical sector. His work has been instrumental in advancing treatments that address critical health issues, particularly in oncology and ophthalmology.
Collaborations
Kim collaborates with esteemed colleagues, including Soon Jae Park and Hye-Shin Chung, to further enhance the impact of his research and inventions.
Conclusion
Yong Mo Kim's contributions to biopharmaceuticals exemplify the importance of innovation in developing effective treatments. His patents reflect a commitment to improving patient outcomes through advanced therapeutic solutions.